Clinical Trials in Georgia

Showing 1721-1740 of 16,324 trials

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

NCT04928677

The purpose of this study to find out whether codrituzumab is a safe treatment that causes few or mild side effects in children and young adults who have solid tumors that express the protein GPC3. The researchers also want to study the way codrituzumab is absorbed, distributed, and cleared from the body.

Primary Extra-cranial Solid TumorRecurrent or Refractory Glypican 3 (GPC3)

Memorial Sloan Kettering Cancer Center50 participantsStarted Jun 2021

Los Angeles, California, United States • Atlanta, Georgia, United States • Boston, Massachusetts, United States +2 more locations

RECRUITINGPhase 1/265 miles

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

NCT07061938

ACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy derived from healthy donors, that is under investigation for the treatment in subjects with Immunoglobulin G4 Related Disease (IgG4-RD)

IgG4 Related Disease

Acepodia Biotech, Inc.30 participantsStarted Jan 2026

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Kahoku-gun, JP, Japan

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

Find Trials by Condition in Georgia

A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant

Observational Study of LUMRYZ in Narcolepsy

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients

Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer

Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors